HPCAL1: A Potential Drug Target and Biomarker (G3241)

Target Name: HPCAL1

NCBI ID: G3241

HPCAL1

HPCAL1: A Potential Drug Target and Biomarker

HPCAL1 (Human Proteomic Atlas Library 1) is a protein that is expressed in a variety of tissues and cells in the human body. It is a member of the HPCAL family of proteins, which are known for their role in intracellular signaling and protein-protein interactions. HPCAL1 has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of HPCAL1 is its role in intracellular signaling. HPCAL1 is a scaffold protein that can interact with a variety of intracellular signaling proteins, including TGF-β1, NF-kappa-B, and PI3K. These proteins are involved in a wide range of cellular processes, including cell growth, differentiation, and inflammation. HPCAL1 has been shown to play a role in regulating the activity of these signaling proteins, and altering their activity has been implicated in a variety of diseases.

In addition to its role in intracellular signaling, HPCAL1 is also involved in the regulation of cellular processes outside of the cell. For example, HPCAL1 has been shown to play a role in regulating the distribution of proteins in the cell, as well as their degradation. This is important for maintaining the stability and integrity of cellular structures and functions, and is implicated in a variety of diseases, including cancer.

As a potential drug target, HPCAL1 is being targeted by a variety of researchers for its potential therapeutic effects. For example, studies have shown that inhibiting the activity of HPCAL1 can lead to a variety of cellular and molecular changes, including increased cell cycle arrest, reduced inflammation, and improved survival in cancer models. Additionally, HPCAL1 has been shown to be expressed in a variety of cancer types, making it a promising target for cancer therapies.

In addition to its potential therapeutic applications, HPCAL1 is also a potential biomarker for a variety of diseases. Its expression has been shown in a variety of tissues and cells, including cancer, fetal tissues, and brain. This makes it a potential indicator of disease status, and its decreased expression has been implicated in a variety of diseases, including cancer.

Overall, HPCAL1 is a protein that is involved in a wide range of cellular processes, including intracellular signaling and cellular regulation. Its potential as a drug target or biomarker makes it an attractive target for researchers studying a variety of diseases. As more research is conducted on HPCAL1, its role in these processes will continue to be understood, and its potential therapeutic and diagnostic applications will be further explored.

Protein Name: Hippocalcin Like 1

Functions: May be involved in the calcium-dependent regulation of rhodopsin phosphorylation

The "HPCAL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HPCAL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets